Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to discuss Arena obesity drug in 2nd quarter
FDA panel to discuss Arena obesity drug in 2nd quarter
FDA panel to discuss Arena obesity drug in 2nd quarter
Submitted by
admin
on February 2, 2012 - 11:06am
Source:
Reuters
News Tags:
Arena
FDA
obesity
lorcaserin
Headline:
FDA panel to discuss Arena obesity drug in 2nd quarter
Do Not Allow Advertisers to Use My Personal information
